Fennec Pharmaceuticals (FENC) Operating Income Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Fennec Pharmaceuticals | 281.48 Mn | 244.70 Mn | 7.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.62% |
| Sep 30, 2025 | 49.68% |
| Jun 30, 2025 | 10.83% |
| Mar 31, 2025 | 26.76% |
| Dec 31, 2024 | 23.87% |
| Sep 30, 2024 | -22.80% |
| Jun 30, 2024 | -0.92% |
| Mar 31, 2024 | 48.11% |
| Dec 31, 2023 | 10.15% |
| Sep 30, 2023 | 18.61% |
| Jun 30, 2023 | -11.85% |
| Mar 31, 2023 | -24.09% |
| Dec 31, 2022 | -19.52% |
| Sep 30, 2022 | -29.30% |
| Jun 30, 2022 | -27.63% |
| Mar 31, 2022 | -35.69% |
| Dec 31, 2021 | -29.71% |
| Sep 30, 2021 | -49.22% |
| Jun 30, 2021 | -40.86% |
| Mar 31, 2021 | -61.08% |
| Dec 31, 2020 | -43.44% |
| Sep 30, 2020 | -76.92% |
| Jun 30, 2020 | -54.58% |
| Mar 31, 2020 | -53.36% |
| Dec 31, 2019 | -35.80% |
| Sep 30, 2019 | -24.65% |
| Jun 30, 2019 | -38.93% |
| Mar 31, 2019 | -37.92% |
| Dec 31, 2018 | -49.48% |
| Sep 30, 2018 | -123.56% |
| Jun 30, 2018 | -23.52% |
| Mar 31, 2018 | -27.24% |
| Dec 31, 2017 | -17.50% |
| Sep 30, 2017 | -28.25% |
| Jun 30, 2017 | -3.42% |
| Mar 31, 2017 | -4.59% |
| Dec 31, 2016 | -4.90% |
| Sep 30, 2016 | 9.79% |
| Jun 30, 2016 | -4.33% |
| Mar 31, 2016 | 14.96% |
| Dec 31, 2015 | 7.55% |
| Sep 30, 2015 | 18.10% |
| Jun 30, 2015 | 26.18% |